FDA Investigator

Hung H Do

Latest inspection on record: Oklahoma City, United States, June 2026 · records back to 2021

Human DrugsAnimal Drugs & Feeds

FDA inspection record · Last updated August 15, 2026

Overview

  • 42 inspections across 42 sites are on record.
  • 164 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-06-17.

At a glance

Inspections

42

Sites

42

Observations

164

Career since

Apr 2021

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Cytovance Biologics Inc.17 Jun 2026Human DrugsOn file
Hanlim Pharm Co. Ltd.24 Apr 2026Human DrugsView 483 →
Rohto-Mentholatum (Vietnam) Co., Ltd.14 Apr 2026Human DrugsView 483 →
LICO Industries, LLC19 Feb 2026Human DrugsView 483 →
Island Kinetics, Inc. d.b.a. CoValence Laboratories23 Jan 2026Human DrugsView 483 →

Sites inspected

Cytovance Biologics Inc.Oklahoma City, United States1 insp.
Hanlim Pharm Co. Ltd.Yongin, Korea (the Republic of)1 insp.
Rohto-Mentholatum (Vietnam) Co., Ltd.Ho Chi Minh, Vietnam1 insp.
LICO Industries, LLCMohave Valley, United States1 insp.

Co-investigators

Investigators who share inspections with this person.

Chad W Rice2 shared
Justin C Oliver1 shared

Full investigator report

Get the verbatim findings behind Hung H Do's 164 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site